All this indicates that detecting LP-PLA2 activity is useful not only for judging the severity of CAD but also for estimating the severity of coronary atherosclerosis, which is consistent with data from Blankenberg [24]. This evidence concerns the gene PLA2G7 and coronary atherosclerosis.